Purpose

Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups). Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 years and older - Diagnosis of one of, isolated injury - Hip fracture - Tibial shaft fracture (with and without associated fibular fracture) - Ankle/pilon fracture - Proximal humerus fracture - Distal radius fracture - English, German, or Spanish speaking - Informed consent obtained, i.e.: - Ability to understand the content of the patient information/ICF - Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP) - Signed and dated EC/IRB approved written informed consent

Exclusion Criteria

  • More than 14 days from day of injury to day of surgery / day of nonoperative treatment decision - Patients with multiple fractures - Pathological fractures due to cancer - Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment - Pregnancy or women planning to conceive within the study period - Patients who are not able to provide independent written informed consent unless defined and IRB/IEC-approved procedures for consenting such vulnerable patients are in place - Prisoners - Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study - Patients unable to likely achieve anticipated Follow-up (FU)

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative
Boston, Massachusetts 02114
Contact:
Neal Chen, MD MPH FRCSC

More Details

Status
Recruiting
Sponsor
AO Innovation Translation Center

Study Contact

Aleksandra Hodor, PhD
+41 44 200 24 81
aleksandra.hodor@aofoundation.org

Detailed Description

More in detail this observational study includes the following sub-projects: I) Weight -bearing and Gait Observation for Fully Individualized Treatment and Aftercare Following Surgery and Trauma Objectives: To analyse the association between automated, sensor-based patient activity and loading data, and clinical (Patient Reported Outcomes [PROs]) and radiographic outcome during fracture healing. II) Recovery Trajectory using PROMIS®: Defining the Recovery Trajectory using PROMIS® to Optimize Decision-making and Outcomes following Extremity Fractures Objectives: 1. To identify the factors predictive of longer term magnitude of limitations after extremity fractures (using PROMs) 2. To assess minimal clinically important difference (MCID) and substantial clinical benefit (SCB) in PROM scores 3. To define recovery trajectories of PROMs i.e. range, normative limits and score thresholds III) Linking PROMIS®: Linking of PROMIS Measures to Legacy Measures in an Orthopaedic Patient Population Objectives: 1. Administer and collect responses to the PROMIS PF/UE and PAIN INT and the four orthopaedic legacy measures in the same group of orthopaedic trauma patients. 2. Apply the methods of item-response theory (IRT) linking to establish a common standardized metric. 3. Develop equations for conversion of a PROMIS PF/UE and PAIN INT score to each of the specified legacy measures and vice-versa.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.